7
report
Targeting Tau — Our Hope to Solving the Dementia Crisis
In our systems-based review of the biomedical landscape supporting research of a cellular protein c
alled tau—a common culprit in a number of neurodegenerative diseases—we make the case that focused strategic investment in tau research and the , At present, no disease-modifying therapies for the pure tauopathies exist. Researchers are working to develop effective therapeutic agents, which include approaches such as decreasing the amount of tau within the brain., Symptomatic Interventions
At present, no disease-modifying therapies for the pure tauopathies exist.
+ Read More
report
Misophonia - A Giving Smarter Guide
video
Giving Smarter in the Age of COVID-19.
October 20 at 9:00 am PDT/12:00 pm EDT
video
Racial Equity: Philanthropy in Reconciliation and Healing.
October 13 at 1:30 pm PDT/4:30 pm EDT
article
Baszucki Brain Research Fund and the Milken Institute Announce Metabolic Mind Award Annual Recipients
SAN MATEO, CA, November 15, 2022 — The Baszucki Brain Research Fund and the Milken Institute ar
e pleased to announce the annual rec
+ Read More
article
Metabolic Mind Award Program Update
The Milken Institute in partnership with the Baszucki Brain Research Fund are pleased to announce th
e individuals selected to receive the 2022 Metabolic Mind Award for their exceptional contributions to the advancement of understanding Ketogenic
+ Read More
article
October 2020: An Update from the Center for Strategic Philanthropy
In this issue
New Publications and Resources »
Advisory Board »